265 (Mycophenolate mofetil 500 mg)
Pill imprint 265 has been identified as Mycophenolate mofetil 500 mg.
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; myasthenia gravis; autoimmune hepatitis; bullous pemphigoid (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 265 (Mycophenolate mofetil 500 mg)
- 500 mg
- Prescription only
- Drug Class:
- Selective immunosuppressants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Ascend Laboratories LLC
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
ferric oxide red
More about mycophenolate mofetil
- Mycophenolate mofetil
- Mycophenolate mofetil capsules
- Mycophenolate mofetil solution
- Mycophenolate mofetil suspension
- Mycophenolate Intravenous (Advanced Reading)
- More (2) »
- Other brands: CellCept
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...